Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel

R. Ben-Ami*, G. Rahav, H. Elinav, I. Kassis, I. Shalit, T. Gottesman, O. Megged, M. Weinberger, P. Ciobotaro, P. Shitrit, G. Weber, A. Paz, D. Miron, I. Oren, J. Bishara, C. Block, N. Keller, D. P. Kontoyiannis, M. Giladi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

The emergence of fluconazole-resistant Candida (FRC) is worrisome, but little is known about susceptibility patterns in different nosocomial settings. We prospectively analysed Candida bloodstream isolates in 18 medical centres in Israel (six tertiary-care and 12 community hospitals). The study included 444 episodes of candidaemia (450 patient-specific isolates, 8.5% fluconazole-resistant). Institutional FRC bloodstream infection rates correlated with annual inpatient days, and were strongly associated with the presence and activity of haematology/oncology services. Infection with Candida krusei and fluconazole-resistant Candida glabrata occurred exclusively in hospitals with >600 beds. These findings suggest that empirical antifungal strategies should be tailored to the nosocomial setting.

Original languageEnglish
Pages (from-to)752-756
Number of pages5
JournalClinical Microbiology and Infection
Volume19
Issue number8
DOIs
StatePublished - Aug 2013
Externally publishedYes

Funding

FundersFunder number
Israeli Society for Infectious Diseases
Merck Sharp and Dohme

    Keywords

    • Candidaemia
    • Drug resistance
    • Epidemiology
    • Fluconazole

    Fingerprint

    Dive into the research topics of 'Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel'. Together they form a unique fingerprint.

    Cite this